Epidemiological profile of severe community-acquired pneumonia in an intensive care unit

Authors

  • Gino Navarro Cordero Caja Costarricense del Seguro Social, Hospital Dr. Rafael A. Calderón Guardia
  • Donato Salas Segura Caja Costarricense del Seguro Social, Hospital Dr. Rafael A. Calderón Guardia

DOI:

https://doi.org/10.51481/amc.v57i1.868

Keywords:

Epidemiology, pneumonia, Streptococcus pneumoniae, intensive care

Abstract

Background: Community-acquired pneumonia is an important and common cause of morbidity and mortality. There are no epidemiological profiles of the population hospitalized in Costa Rica due to this cause. The aim of this study was to identify the demographic, clinical and microbiological profile of patients admitted to the intensive care unit during thirteen months.Method: A database which included the main clinical and laboratory variables of patients admitted with a diagnosis of severe community acquired pneumonia was created. In order to obtain microbiological identification blood cultures, bronchial aspirate and real-time polymerase chain reaction analysis were performed.Results: Twenty eight patients were recruited. The infectious agent was identified in 90% of the cases. Ages ranged from 18 to 65 years old. In 53% of cases a comorbidity was identified, the most common ones were high blood pressure, diabetes mellitus, chronic lung disease, immunosuppression, chronic kidney disease and obesity. Pneumococcus was the most frequently identified germ, found in 53.5% of cases, followed by respiratory viruses in 18.9% and Haemophilus influenza in 7.1% of cases. The most commonly used antibiotics were third-generation cephalosporines, macrolides and fluoroquinolones. Mortality was 21%.Conclusion: The most frequent etiologic agent was Pneumococcus sp. and the empiric antibiotic therapy was consistent with this finding. Respiratory virus area major cause of community-acquired pneumonia. Atypical microorganisms were not isolated and Staphylococcus sp was always identified in combination with other germs.

Downloads

Download data is not yet available.

References

Brown S, Dean N. Defining severe pneumonia. Clin Chest Med. 2011;32:469- 479.

Mandell L, Wunderink R, Anzueto A, Bartlett J, Campbell D, Nathan C, et al. Infectious Diseases Society of America/American thoracic society consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults IDSA/ATS Guidelines for CAP in Adults. 2007;44 (Suppl 2):1-46.

Nair G, Niederman M. Community-acquired pneumonia: An unfinished battle. Med Clin N Am. 2011;95:1143-1161.

Sligl W, Marrie T. Severe community- acquired pneumonia, Crit Care Clin.2013;29:563-601

Upadhyay S, Niederman M. Biomarkers: What is their benefit in the identification of infection, severity assessment, and management of communityacquired pneumonia. Infect Dis Clin N Am. 2013;27:19-31.

Peyrani P, Ramírez J. What is the association of cardiovascular events with clinical failure in patients with community - acquired pneumonia. Infect Dis Clin N Am. 2013;27:205-2010.

Urbieta E, Medina C, Capelastegui A, España P, Ajuria I, Vrotsou K. Proteína C reactiva, procalcitonina y proadrenomodulina en la evolución de neumonías hospitalizadas. Lab Clin. 2011;4:23-29.

Pavia A. What is the role of respiratory viruses in community-acquired pneumonia. Infect Dis Clin N Am. 2013;27:157-175.

Sibila O, Restrepo M, Anzueto A. What is the best antimicrobial treatment for severe community- acquired pneumonia (Including the role of steroids and statins and other immunomodulatory agents). Infect Dis Clin N Am. 2013;27:133-147.

Salluh JL, Rabello LS, Rosolem MM, Soares M, Bozza FA, Verdeal JC, et al. The impact of coagulation parameters on the outcomes of patients with severe community-acquired pneumonia requiring intensive care unit admission. J Crit Care. 2011;26:496-501

Lutfiyya MN, Henley E, Chang LF, Reyburn SW. Diagnosis and treatment of community-acquired pneumonia. Am Fam Physician. 2006;73:442-450.

Restrepo M, Anzueto A. Severe Community- Acquired Pneumonia. Infect Dis Clin North Am. 2009;23:503-520.

Nazarian DJ, Eddy OL, Lukens TW, Weingart SD, Decker WW. Clinical Policy: Critical Issues in the Management of Adult Patients Presenting to the Emergency Department with Community-Acquired Pneumonia. Ann Emerg Med. 2009;54:704-731.

Arguedas A, Abdelnour A, Soley C, Jiménez E, Jiménez AL, Ramcharran D, et al. Vigilancia epidemiológica prospectiva de la enfermedad neumocóccica invasora y de la neumonía en niños de San José, Costa Rica. Act méd costarric.

;54:252-261

Published

2015-01-30 — Updated on 2015-01-30

Versions

How to Cite

Epidemiological profile of severe community-acquired pneumonia in an intensive care unit. (2015). Acta Médica Costarricense , 57(1), 33-37. https://doi.org/10.51481/amc.v57i1.868